Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression

Lymphoma
17/05/2020

Badar T, et al. Br J Haematol 2020.

NO ABSTRACT